SCHEMBL25537342

SCHEMBL25537342

CC1(C)c2cc(-c3ccc(-c4ccc(-c5cc(-c6cccc(-c7cccnc7)c6)nc(-c6ccccc6)n5)c5ccccc45)cc3)ccc2-c2c1ccc1ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.38
CYP11B1 P15538 2/20 0.38
CYP17A1 P05093 1/20 0.38
CYP11B2 P19099 1/20 0.38
DHODH Q02127 1/20 0.37
PDK2 Q15119 2/20 0.35
TNF P01375 1/20 0.35
CYP2C9 P11712 4/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GLA P06280 1/20 0.35
TSHR P16473 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
GPR84 Q9NQS5 1/20 0.35
PSD A5PKW4 1/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25536290 0.97 CYP11B1 (0.39) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL25537714 0.96 CYP11B1 (0.38) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL25537337 0.96 DHODH (0.40) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL25537439 0.95 CYP11B1 (0.37) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL22037467 0.95 DHODH (0.41) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL22037935 0.95 DHODH (0.41) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL22037456 0.95 DHODH (0.41) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL22037638 0.95 DHODH (0.41) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL22037989 0.94 DHODH (0.41) CYP19A1CYP11B1CYP17A1CYP11B2DHODH
SCHEMBL25539891 0.94 DHODH (0.39) CYP19A1CYP11B1CYP17A1CYP11B2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM CYP19A1 613/4885CYP11B1 2526/4885CYP17A1 2030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.